Frontier Capital Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.8M Buy
+342,570
New +$23.4M 0.25% 153
2024
Q4
Sell
-1,269,827
Closed -$72.7M 291
2024
Q3
$72.7M Buy
1,269,827
+423,600
+50% +$24.3M 0.68% 37
2024
Q2
$44.3M Buy
846,227
+602,194
+247% +$26.4M 0.44% 85
2024
Q1
$9.93M Buy
244,033
+66,658
+38% +$2.5M 0.09% 218
2023
Q4
$6.56M Buy
177,375
+273
+0.2% +$10.3K 0.07% 221
2023
Q3
$6.77M Buy
177,102
+131,643
+290% +$5.39M 0.07% 218
2023
Q2
$1.64M Buy
+45,459
New +$1.55M 0.02% 249

Other funds holding HALO

Frontier Capital Management's HALO Position: Q2 2026 in Review

Frontier Capital Management opened a new position in Halozyme (HALO) in Q2 2026: 342,570 shares worth $26.8M. The stake represents 0.25% of the portfolio and ranks #153 among its holdings. This is a return to the name: Frontier Capital Management previously reported a position in HALO as recently as Q3 2024.

Frontier Capital Management first reported a position in HALO in Q2 2023 and has held it in 7 quarters since. The position peaked at $72.7M in Q3 2024. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Frontier Capital Management held 342,570 shares of Halozyme worth $26.8M as of Q2 2026.
  • Halozyme was a new Frontier Capital Management position in Q2 2026.
  • Halozyme made up 0.25% of Frontier Capital Management's portfolio in Q2 2026, its #153 holding.
  • Frontier Capital Management first reported a position in Halozyme in Q2 2023 and has held it in 7 quarters since.
  • Frontier Capital Management's Halozyme position peaked at $72.7M in Q3 2024.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Frontier Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.